Literature DB >> 12734226

Quality control for beta-lactam susceptibility testing with a well-defined collection of Enterobacteriaceae and Pseudomonas aeruginosa strains in Spain.

Rafael Cantón1, Elena Loza, María Del Carmen Conejo, Fernando Baquero, Luis Martínez-Martínez.   

Abstract

Eighteen Enterobacteriaceae and Pseudomonas aeruginosa strains, 16 of them with well-defined beta-lactam resistance mechanisms, were sent to 52 Spanish microbiology laboratories. Interpretative categories for 8 extended-spectrum beta-lactams were collected. Participating laboratories used their own routine susceptibility testing procedures (88% automatic systems, 10% disk diffusion, and 2% agar dilution). Control results were established by two independent reference laboratories by applying the NCCLS microdilution method and interpretative criteria. Interpretative discrepancies were observed in 16% of the results (4.4% for cefepime, 3.0% for aztreonam, 2.8% for piperacillin-tazobactam, 1.7% for cefotaxime [CTX] and ceftazidime, 1.1% for ceftriaxone, 0.9% for meropenem, and 0.3% for imipenem). High consistency with reference values (<5% of major plus very major errors) was observed with (i) American Type Culture Collection quality control strains; (ii) strains with low-efficiency mechanisms inactivating extended-spectrum beta-lactams, such as OXA-1-producing Escherichiacoli or SHV-1-hyperproducing Klebsiella pneumoniae; (iii) strains with highly efficient mechanisms, such as SHV-5 porin-deficient K. pneumoniae, CTX-M-10 in Enterobacter cloacae hyperproducing AmpC, and P. aeruginosa with the MexAB OprM efflux phenotype or hyperproducing AmpC. Low consistency (>30% major plus very major errors) was detected in K1-producing Klebsiella oxytoca, CTX-M-9-producing E. coli, and in OprD(-) P. aeruginosa strains. Extended-spectrum beta-lactamase (ESBL)-producing strains accounted for 86% of very major errors. Recognition of the ESBL phenotype was particularly low in Enterobacter cloacae strains (<35%), due to the lack of NCCLS-specific rules in this genus. A K1-producing K. oxytoca was misidentified by 10% of laboratories as an ESBL producer. The use of well-defined resistant strains is useful for improving proficiency in susceptibility testing in clinical laboratories.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734226      PMCID: PMC154698          DOI: 10.1128/JCM.41.5.1912-1918.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

Review 1.  New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy.

Authors:  K Bush
Journal:  Clin Infect Dis       Date:  2001-03-21       Impact factor: 9.079

2.  Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing.

Authors:  R Cantón; M Pérez-Vázquez; A Oliver; B Sánchez Del Saz; M O Gutiérrez; M Martínez-Ferrer; F Baquero
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 3.  [Recommendations from MENSURA for selection of antimicrobial agents for susceptibility testing and criteria for the interpretation of antibiograms].

Authors: 
Journal:  Rev Esp Quimioter       Date:  2000-03       Impact factor: 1.553

4.  Of Pseudomonas, porins, pumps and carbapenems.

Authors:  D M Livermore
Journal:  J Antimicrob Chemother       Date:  2001-03       Impact factor: 5.790

5.  Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.

Authors:  C D Steward; D Wallace; S K Hubert; R Lawton; S K Fridkin; R P Gaynes; J E McGowan; F C Tenover
Journal:  Diagn Microbiol Infect Dis       Date:  2000-09       Impact factor: 2.803

6.  Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles.

Authors:  L Martínez-Martínez; M C Conejo; A Pascual; S Hernández-Allés; S Ballesta; E Ramírez De Arellano-Ramos; V J Benedí; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

7.  Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing.

Authors:  F C Tenover; M J Mohammed; J Stelling; T O'Brien; R Williams
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

8.  Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut.

Authors:  F C Tenover; M J Mohammed; T S Gorton; Z F Dembek
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 9.  Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult-to-detect resistance mechanisms.

Authors:  J H Jorgensen; M J Ferraro
Journal:  Clin Infect Dis       Date:  2000-04-28       Impact factor: 9.079

10.  Beta-lactam stability in frozen microdilution PASCO MIC panels using strains with known resistance mechanisms as biosensors.

Authors:  S Valdezate; J Martínez-Beltrán; L de Rafael; F Baquero; R Cantón
Journal:  Diagn Microbiol Infect Dis       Date:  1996-10       Impact factor: 2.803

View more
  6 in total

1.  Detection of cefotaxime-resistant CTX-M-3 in clinical isolates of Serratia marcescens.

Authors:  Mei-Fen Tsou; Wen-Liang Yu; Siu Wan Hung; Chizh-Ju Chi; Ssu Ching Chen; Lii-Tzu Wu
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

2.  Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria.

Authors:  Maria Grazia Menozzi; Ulrich Eigner; Silvia Covan; Sabina Rossi; Pietro Somenzi; Giuseppe Dettori; Carlo Chezzi; Anne-Marie Fahr
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

3.  Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: a multicenter external proficiency study using a well-defined collection of Escherichia coli strains.

Authors:  Aida Ripoll; Juan-Carlos Galán; Cristina Rodríguez; Nuria Tormo; Concepción Gimeno; Fernando Baquero; Luis Martínez-Martínez; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

4.  A comparison of antibiotic disks from different sources on Quicolor and Mueller-Hinton agar media in evaluation of antibacterial susceptibility testing.

Authors:  Neda Saffari; Siavosh Salmanzadeh-Ahrabi; Ahya Abdi-Ali; Mohsen Rezaei-Hemami
Journal:  Iran J Microbiol       Date:  2016-10

5.  Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data.

Authors:  N Stoesser; E M Batty; D W Eyre; M Morgan; D H Wyllie; C Del Ojo Elias; J R Johnson; A S Walker; T E A Peto; D W Crook
Journal:  J Antimicrob Chemother       Date:  2013-05-30       Impact factor: 5.790

6.  Reporting antimicrobial susceptibilities and resistance phenotypes in Staphylococcus spp.: a nationwide proficiency study.

Authors:  Felipe Fernández-Cuenca; Inmaculada López-Hernández; Emilia Cercenado; Carmen Conejo; Nuria Tormo; Concha Gimeno; Alvaro Pascual
Journal:  J Antimicrob Chemother       Date:  2021-04-13       Impact factor: 5.790

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.